lapatinib has been researched along with aminolevulinic acid in 2 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (aminolevulinic acid) | Trials (aminolevulinic acid) | Recent Studies (post-2010) (aminolevulinic acid) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 6,475 | 665 | 2,740 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Howley, R; Mansi, M; Restrepo, J; Shinde, J | 1 |
| Chandratre, S; Chen, B; Howley, R; Mansi, M | 1 |
2 other study(ies) available for lapatinib and aminolevulinic acid
| Article | Year |
|---|---|
Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Topics: Aminolevulinic Acid; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Screening Assays, Antitumor; Ferrochelatase; Humans; Kidney Neoplasms; Lapatinib; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Signal Transduction | 2020 |
Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Topics: Aminolevulinic Acid; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Ferrochelatase; Fluorescence; Glioma; Humans; Lapatinib; Neoplasm Proteins; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2022 |